Traditionelle chinesische Medizin – Relevant für die Behandlung der rheumatoiden Arthritis?

Zusammenfassung

Die Traditionelle Chinesische Medizin (TCM) hat eine lange Tradition und basiert auf einem eigenen Medizinsystem, welches die physiologischen Abläufe im Körper und die Entstehung von Krankheiten beschreibt. Einige Studien deuten darauf hin, dass die TCM bei entzündlich-rheumatischen Erkrankungen (insbesondere der rheumatoiden Arthritis, RA) wirksam sein könnte. Hauptanwendungsmethoden der TCM bei einer RA stellen die Akupunktur als auch chinesische Heilkräuter dar. Durch die Anwendung der TCM könnte die Wirkung der Disease-modifying Antirheumatic Drugs und Symptomlinderung verbessert als auch die Nebenwirkungsrate reduziert werden. Limitierend für die TCM ist, dass eine systematische wissenschaftliche Evaluation der TCM bisher jedoch fehlt.

Abstract

Traditional Chinese Medicine (TCM) has a long tradition and is based on its own system of medicine, which describes the physiological processes in the body and the development of diseases. Some studies suggest that TCM may be effective in inflammatory rheumatic diseases (especially rheumatoid arthritis, RA). The main application methods of TCM in RA include acupuncture and Chinese medicinal herbs. The application of TCM could possibly improve the effect of disease-modifying antirheumatic drugs and symptom relief, as well as reduce the rate of side effects. A limiting factor for TCM is that a systematic scientific evaluation of TCM is still missing.

Schlüsselwörter

Rheumatoide Arthritis - traditionelle chinesische Medizin - Akupunktur - Arzneikräuter

Key words

rheumatoid arthritis - traditional chinese medicine - acupuncture - medicinal herbs

Publication History

Article published online:
30 August 2023

• Literatur

• 1 Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet 2016; 388: 2023-2038 DOI: 10.1016/s0140-6736(16)30173-8.
• 2 Smolen JS, Landewé RBM, Bergstra SA. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2023; 82: 3-18 DOI: 10.1136/ard-2022-223356.
• 3 Manheimer E, Wieland S, Kimbrough E. et al. Evidence from the Cochrane Collaboration for Traditional Chinese Medicine therapies. J Altern Complement Med 2009; 15: 1001-1014 DOI: 10.1089/acm.2008.0414.
• 4 Eigenschink M, Bellach L, Leonard S. et al. Cross-sectional survey and Bayesian network model analysis of traditional Chinese medicine in Austria: investigating public awareness, usage determinants and perception of scientific support. BMJ Open 2023; 13: e060644 DOI: 10.1136/bmjopen-2021-060644.
• 5 Eardley S, Bishop FL, Prescott P. et al. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed 2012; 19: 18-28 DOI: 10.1159/000342708.
• 6 Xia X, May BH, Zhang AL. et al. Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products. Evid Based Complement Alternat Med 2020; 2020: 7531967 DOI: 10.1155/2020/7531967.
• 7 Pan HD, Xiao Y, Wang WY. et al. Traditional Chinese Medicine as a Treatment for Rheumatoid Arthritis: From Empirical Practice to Evidence-Based Therapy. Engineering 2019; 5: 895-906 DOI: 10.1016/j.eng.2019.01.018.
• 8 Su XZ, Miller LH. The discovery of artemisinin and the Nobel Prize in Physiology or Medicine. Sci China Life Sci 2015; 58: 1175-1179 DOI: 10.1007/s11427-015-4948-7.
• 9 Efthimiou P, Kukar M, Mackenzie CR. Complementary and alternative medicine in rheumatoid arthritis: no longer the last resort!. Hss j 2010; 6: 108-111 DOI: 10.1007/s11420-009-9133-8.
• 10 Saydah SH, Eberhardt MS. Use of complementary and alternative medicine among adults with chronic diseases: United States 2002. J Altern Complement Med 2006; 12: 805-812 DOI: 10.1089/acm.2006.12.805.
• 11 Hamre HJ, Pham VN, Kern C. et al. A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference. Patient Prefer Adherence 2018; 12: 375-397 DOI: 10.2147/ppa.S145221.
• 12 Manek NJ, Crowson CS, Ottenberg AL. et al. What rheumatologists in the United States think of complementary and alternative medicine: results of a national survey. BMC Complement Altern Med 2010; 10: 5 DOI: 10.1186/1472-6882-10-5.
• 13 Focks C. Leitfaden Chinesische Medizin – Therapie. Urban & Fischer; 2018
• 14 Chen Y, Li D, Li N. et al. Role of nerve signal transduction and neuroimmune crosstalk in mediating the analgesic effects of acupuncture for neuropathic pain. Front Neurol 2023; 14: 1093849 DOI: 10.3389/fneur.2023.1093849.
• 15 Hui KK, Marina O, Liu J. et al. Acupuncture, the limbic system, and the anticorrelated networks of the brain. Auton Neurosci 2010; 157: 81-90 DOI: 10.1016/j.autneu.2010.03.022.
• 16 Zijlstra FJ, van den Berg-de Lange I, Huygen FJ. et al. Anti-inflammatory actions of acupuncture. Mediators Inflamm 2003; 12: 59-69 DOI: 10.1080/0962935031000114943.
• 17 Kavoussi B, Ross BE. The neuroimmune basis of anti-inflammatory acupuncture. Integr Cancer Ther 2007; 6: 251-257 DOI: 10.1177/1534735407305892.
• 18 Pan TC, Tsai YH, Chen WC. et al. The effects of laser acupuncture on the modulation of cartilage extracellular matrix macromolecules in rats with adjuvant-induced arthritis. PLoS One 2019; 14: e0211341 DOI: 10.1371/journal.pone.0211341.
• 19 Casimiro L, Barnsley L, Brosseau L. et al. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev 2005; 2005: Cd003788 DOI: 10.1002/14651858.CD003788.pub2.
• 20 Ouyang BS, Gao J, Che JL. et al. Effect of electro-acupuncture on tumor necrosis factor-α and vascular endothelial growth factor in peripheral blood and joint synovia of patients with rheumatoid arthritis. Chin J Integr Med 2011; 17: 505-509 DOI: 10.1007/s11655-011-0783-2.
• 21 Zeng C, Bai X, Qin H. et al. Effect of adjuvant therapy with electroacupuncture on bone turnover markers and interleukin 17 in patients with rheumatoid arthritis. J Tradit Chin Med 2019; 39: 582-586
• 22 Tam LS, Leung PC, Li TK. et al. Acupuncture in the treatment of rheumatoid arthritis: a double-blind controlled pilot study. BMC Complement Altern Med 2007; 7: 35 DOI: 10.1186/1472-6882-7-35.
• 23 Wan R, Fan Y, Zhao A. et al. Comparison of Efficacy of Acupuncture-Related Therapy in the Treatment of Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials. Front Immunol 2022; 13: 829409 DOI: 10.3389/fimmu.2022.829409.
• 24 Li H, Man S, Zhang L. et al. Clinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials. Evid Based Complement Alternat Med 2022; 2022: 5264977 DOI: 10.1155/2022/5264977.
• 25 Zhang Y, Wang C. Acupuncture and Chronic Musculoskeletal Pain. Curr Rheumatol Rep 2020; 22: 80 DOI: 10.1007/s11926-020-00954-z.
• 26 Maradit-Kremers H, Crowson CS, Nicola PJ. et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005; 52: 402-411 DOI: 10.1002/art.20853.
• 27 Peters MJ, van Halm VP, Voskuyl AE. et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 2009; 61: 1571-1579 DOI: 10.1002/art.24836.
• 28 Wu MY, Huang MC, Liao HH. et al. Acupuncture decreased the risk of coronary heart disease in patients with rheumatoid arthritis in Taiwan: a Nationwide propensity score-matched study. BMC Complement Altern Med 2018; 18: 341 DOI: 10.1186/s12906-018-2384-5.
• 29 Chen WJ, Livneh H, Chen CH. et al. Does Use of Acupuncture Reduce the Risk of Type 2 Diabetes Mellitus in Patients With Rheumatoid Arthritis? Evidence From a Universal Coverage Health Care System. Front Med (Lausanne) 2021; 8: 752556 DOI: 10.3389/fmed.2021.752556.
• 30 Brinkhaus B, Ortiz M, Dietzel J. et al. Acupuncture for pain and allergic rhinitis-from clinical experience to evidence. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020; 63: 561-569 DOI: 10.1007/s00103-020-03127-6.
• 31 Han R, Ren HC, Zhou S. et al. Conventional disease-modifying anti-rheumatic drugs combined with Chinese Herbal Medicines for rheumatoid arthritis: A systematic review and meta-analysis. J Tradit Complement Med 2022; 12: 437-446 DOI: 10.1016/j.jtcme.2022.01.005.
• 32 Tang X, Liu Z, Yang Z. et al. The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis. Front Pharmacol 2021; 12: 686360 DOI: 10.3389/fphar.2021.686360.
• 33 Yang M, Guo MY, Luo Y. et al. Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial. Chin J Integr Med 2017; 23: 496-503 DOI: 10.1007/s11655-016-2650-7.
• 34 He DY, Dai SM. Anti-inflammatory and immunomodulatory effects of paeonia lactiflora pall., a traditional chinese herbal medicine. Front Pharmacol 2011; 2: 10 DOI: 10.3389/fphar.2011.00010.
• 35 Liu DF, Wei W, Song LH. Protective effect of paeoniflorin on immunological liver injury induced by bacillus Calmette-Guerin plus lipopolysaccharide: modulation of tumour necrosis factor-alpha and interleukin-6 MRNA. Clin Exp Pharmacol Physiol 2006; 33: 332-339 DOI: 10.1111/j.1440-1681.2006.04371.x.
• 36 Chen Z, Li XP, Li ZJ. et al. Reduced hepatotoxicity by total glucosides of paeony in combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis. Int Immunopharmacol 2013; 15: 474-477 DOI: 10.1016/j.intimp.2013.01.021.
• 37 Wang Q, Li XK. Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol 2011; 11: 373-376 DOI: 10.1016/j.intimp.2010.11.018.
• 38 Tong B, Yuan X, Dou Y. et al. Sinomenine induces the generation of intestinal Treg cells and attenuates arthritis via activation of aryl hydrocarbon receptor. Lab Invest 2016; 96: 1076-1086 DOI: 10.1038/labinvest.2016.86.
• 39 Chen XM, Huang RY, Huang QC. et al. Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis. Evid Based Complement Alternat Med 2015; 2015: 910376 DOI: 10.1155/2015/910376.
• 40 Huang RY, Pan HD, Wu JQ. et al. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial. Phytomedicine 2019; 57: 403-410 DOI: 10.1016/j.phymed.2018.12.030.
• 41 Lai K, Xu L, Jin C. et al. Technetium-99 conjugated with methylene diphosphonate (99Tc-MDP) inhibits experimental choroidal neovascularization in vivo and VEGF-induced cell migration and tube formation in vitro. Invest Ophthalmol Vis Sci 2011; 52: 5702-5712 DOI: 10.1167/iovs.10-6370.
• 42 Fu Q, Feng P, Sun LY. et al. A double-blind, double-dummy, randomized controlled, multicenter trial of 99Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis. Chin Med J (Engl) 2021; 134: 1457-1464 DOI: 10.1097/cm9.0000000000001527.
• 43 Jiang Q, Zhou XY, Wang L. et al. A one-year evaluation of radiographic progression in patients with rheumatoid arthritis treated by Qingre Huoxue Decoction (). Chin J Integr Med 2012; 18: 256-261 DOI: 10.1007/s11655-011-0793-0.
• 44 Gong X, Liu WX, Tang XP. et al. Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial. Front Pharmacol 2021; 12: 679588 DOI: 10.3389/fphar.2021.679588.
• 45 Song CY, Xu YG, Lu YQ. Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects. J Zhejiang Univ Sci B 2020; 21: 280-290 DOI: 10.1631/jzus.B1900607.
• 46 Chen BJ. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. Leuk Lymphoma 2001; 42: 253-265 DOI: 10.3109/10428190109064582.
• 47 Tao X, Cush JJ, Garret M. et al. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol 2001; 28: 2160-2167
• 48 Wang HL, Jiang Q, Feng XH. et al. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis. BMC Complement Altern Med 2016; 16: 215 DOI: 10.1186/s12906-016-1194-x.
• 49 Zhou YZ, Zhao LD, Chen H. et al. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study. Arthritis Res Ther 2018; 20: 70 DOI: 10.1186/s13075-018-1563-6.
• 50 Zhang J, Zhou Y, Ma Z. Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking. Ann Med 2021; 53: 1090-1098 DOI: 10.1080/07853890.2021.1918345.
• 51 Han R, Rostami-Yazdi M, Gerdes S. et al. Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases. Br J Clin Pharmacol 2012; 74: 424-436 DOI: 10.1111/j.1365-2125.2012.04221.x.
• 52 Fu Q, Zhu Y, Fang Y. et al. Efficacy and Safety of Tripterygium Wilfordii Glycoside Tablets Combined with Acitretin Capsules in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial. Appl Bionics Biomech 2022; 2022: 2252500 DOI: 10.1155/2022/2252500.
• 53 Li Y, Zhu W, He H. et al. Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis. Front Pharmacol 2021; 12: 691031 DOI: 10.3389/fphar.2021.691031.
• 54 Lin N, Zhang YQ, Jiang Q. et al. Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis. Front Pharmacol 2020; 11: 608703 DOI: 10.3389/fphar.2020.608703.
• 55 Goldbach-Mansky R, Wilson M, Fleischmann R. et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Ann Intern Med 2009; 151: w249-251 DOI: 10.7326/0003-4819-151-4-200908180-00005.
• 56 Lv QW, Zhang W, Shi Q. et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis 2015; 74: 1078-1086 DOI: 10.1136/annrheumdis-2013-204807.
• 57 Luo Y, Hou X, Xi A. et al. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis. J Ethnopharmacol 2023; 307: 116211 DOI: 10.1016/j.jep.2023.116211.
• 58 Tao X, Lipsky PE. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North Am 2000; 26: 29-50 viii DOI: 10.1016/s0889-857x(05)70118-6.
• 59 Gökmen MR, Cosyns JP, Arlt VM. et al. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review. Ann Intern Med 2013; 158: 469-477 DOI: 10.7326/0003-4819-158-6-201303190-00006.
• 60 Lai MN, Wang SM, Chen PC. et al. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 2010; 102: 179-186 DOI: 10.1093/jnci/djp467.
• 61 Liu R, Li X, Huang N. et al. Toxicity of traditional Chinese medicine herbal and mineral products. Adv Pharmacol 2020; 87: 301-346 DOI: 10.1016/bs.apha.2019.08.001.
• 62 Schieman C, Rudmik LR, Dixon E. et al. Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients. Can J Surg 2009; 52: 422-426
• 63 Liu SH, Chuang WC, Lam W. et al. Safety surveillance of traditional Chinese medicine: current and future. Drug Saf 2015; 38: 117-128 DOI: 10.1007/s40264-014-0250-z.
• 64 Fuchs B, Saikkonen K, Helander M. Glyphosate-Modulated Biosynthesis Driving Plant Defense and Species Interactions. Trends Plant Sci 2021; 26: 312-323 DOI: 10.1016/j.tplants.2020.11.004.
• 65 Holzapfel CSR, Heuberger H, Schmücker R. et al. Qualität vier chinesischer Heilpflanzen aus bayerischem Versuchsanbau im Vergleich zu Importware – heimisch produzierte TCM-Drogen für den Praxisalltag. Chinesische Medizin/Chinese Medicine 2016; 31: 207-218
• 66 Jiang M, Zha Q, Zhang C. et al. Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial. Sci Rep 2015; 5: 9700 DOI: 10.1038/srep09700.
• 67 He YT, Ou AH, Yang XB. et al. Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study. Rheumatol Int 2014; 34: 1647-1655 DOI: 10.1007/s00296-014-3010-6.
• 68 Bäumler P, Zhang W, Stübinger T. et al. Acupuncture-related adverse events: systematic review and meta-analyses of prospective clinical studies. BMJ Open 2021; 11: e045961 DOI: 10.1136/bmjopen-2020-045961.
• 69 Won J, Lee JH, Bang H. et al. Safety of acupuncture by Korean Medicine Doctors: a prospective, practice-based survey of 37,490 consultations. BMC Complement Med Ther 2022; 22: 300 DOI: 10.1186/s12906-022-03782-z.
• 70 Melchart D, Hager S, Dai J. et al. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine – A Retrospective Analysis. Forsch Komplementmed 2016; 23: 21-28 DOI: 10.1159/000444983.
• 71 Shaw D. Toxicological risks of Chinese herbs. Planta Med 2010; 76: 2012-2018 DOI: 10.1055/s-0030-1250533.
• 72 Teschke R, Zhang L, Long H. et al. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol 2015; 14: 7-19
• 73 Teschke R, Larrey D, Melchart D. et al. Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs. Medicines (Basel) 2016; 3 DOI: 10.3390/medicines3030018.
• 74 Zhang P, Ye Y, Yang X. et al. Systematic Review on Chinese Herbal Medicine Induced Liver Injury. Evid Based Complement Alternat Med 2016; 2016: 3560812 DOI: 10.1155/2016/3560812.
• 75 Lai MN, Lai JN, Chen PC. et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 2009; 14: 227-234 DOI: 10.1111/j.1440-1797.2008.01061.x.
• 76 Wang SM, Lai MN, Wei A. et al. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid. PLoS One 2014; 9: e105218 DOI: 10.1371/journal.pone.0105218.
• 77 Chan TY. Incidence and Causes of Aconitum Alkaloid Poisoning in Hong Kong from 1989 to 2010. Phytother Res 2015; 29: 1107-1111 DOI: 10.1002/ptr.5370.
• 78 Li L, Yin Tang L, Liang B. et al. Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines. Reprod Toxicol 2019; 89: 45-53 DOI: 10.1016/j.reprotox.2019.06.001.
• 79 Chan TY. A probable case of amygdalin-induced peripheral neuropathy in a vegetarian with vitamin B12 deficiency. Ther Drug Monit 2006; 28: 140-141 DOI: 10.1097/01.ftd.0000179419.40584.15.
• 80 Nobakht M, Fattahi M, Hoormand M. et al. A study on the teratogenic and cytotoxic effects of safflower extract. J Ethnopharmacol 2000; 73: 453-459 DOI: 10.1016/s0378-8741(00)00324-x.
• 81 Chuang CH, Doyle P, Wang JD. et al. Herbal medicines used during the first trimester and major congenital malformations: an analysis of data from a pregnancy cohort study. Drug Saf 2006; 29: 537-548 DOI: 10.2165/00002018-200629060-00006.
• 82 Shi Y, Tang R, Luo F. et al. The Diagnosis and Management of Allergic Reactions Caused by Chinese Materia Medica. Clin Rev Allergy Immunol 2022; 62: 103-122 DOI: 10.1007/s12016-020-08812-7.
• 83 Lin CC, Chan TY, Deng JF. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med 2004; 43: 574-579 DOI: 10.1016/j.annemergmed.2003.10.046.
• 84 Tang S, Ren J, Kong L. et al. Ephedrae Herba: A Review of Its Phytochemistry, Pharmacology, Clinical Application, and Alkaloid Toxicity. Molecules 2023; 28 DOI: 10.3390/molecules28020663.